Element Secures $175M From Samsung Electronics (opens original article in a new tab)

Element Biosciences raised $175 million from Samsung Electronics to expand its genomics technology platforms and global market reach.

• Element Biosciences secured $175M in Series E funding from Samsung Electronics
• The funding will support commercialization of sequencing platforms and expansion into new markets
• Element plans to launch AVITI Dx and enhance existing AVITI platforms with new analysis capabilities